Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000389208 | SCV000401697 | uncertain significance | Neurofibromatosis, familial spinal | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000294916 | SCV000401698 | uncertain significance | Café-au-lait macules with pulmonary stenosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000349802 | SCV000401699 | uncertain significance | Neurofibromatosis, type 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000395451 | SCV000401700 | uncertain significance | Neurofibromatosis-Noonan syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000481991 | SCV000571937 | likely benign | not provided | 2016-10-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |